RainDance Technologies is a big data genomics company that has raised $35 million in debt financing from Capital Royalty Partners. The funding will be used for accelerating growth and supporting product development. RainDance has raised a total of over $100 million thus far.
Founded eight years ago, RainDance Technologies develops genomic tools that offers researchers at hospitals, institutions, and biotech companies an ultra-sensitive way to detect cancer and other genetic diseases, according to GigaOM.
?The human genome project has introduced the world to an entire world of new information and insights relative to the basis of human physiology,? stated RainDance CEO and president Roopom Banerjee.
Based in Billerica, Mass., RainDance is backed by investors like Mohr Davidow Ventures, Quaker BioVentures, and Alloy Ventures. Myriad Genetics is also an investor in RainDance.